Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 7c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Edwards Lifesciences (EW) Target Lifted to $94 at Jefferies Post Q1
April 25, 2014 11:17 AM EDTJefferies analyst Raj Denhoy lifted estimates and his price target on Buy-rated Edwards Lifesciences (NYSE: EW) price target of $94.00 (from $72.00) following solid Q1 results.
Denhoy SAID, "1Q TAVR upside was fueled by notable strength in Europe... More
